SCHEMBL30200280

SCHEMBL30200280

COc1c(C(=O)CBr)cc2c(c1OC)OCCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.41
CTNNB1 P35222 3/20 0.40
WNT3A P56704 3/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TARBP2 Q15633 1/20 0.37
LMNA P02545 2/20 0.36
HSD17B10 Q99714 2/20 0.36
GPX4 P36969 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
HIF1A Q16665 1/20 0.35
HPGDS O60760 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15988782 1.00 PLK1 (0.41) PLK1CTNNB1WNT3AKDM4EALDH1A1
SCHEMBL15988784 0.82 KDM4E (0.50) PLK1CTNNB1WNT3AKDM4EALDH1A1
SCHEMBL15988858 0.81 PLK1 (0.45) PLK1CTNNB1WNT3AKDM4EALDH1A1
SCHEMBL15988860 0.80 KDM4E (0.46) PLK1CTNNB1WNT3AKDM4EALDH1A1
SCHEMBL15979743 0.79 CTNNB1 (0.53) CTNNB1WNT3AALDH1A1HPGDNPSR1
SCHEMBL15979866 0.78 MAPT (0.53) CTNNB1WNT3AALDH1A1MEN1KMT2A
SCHEMBL17929679 0.78 CTNNB1 (0.57) CTNNB1WNT3AALDH1A1L3MBTL1HPGD
SCHEMBL15979902 0.78 CTNNB1 (0.70) CTNNB1WNT3AKDM4EALDH1A1MEN1
SCHEMBL15979899 0.77 CTNNB1 (0.57) CTNNB1WNT3AKDM4EALDH1A1HPGD
SCHEMBL15979878 0.77 CTNNB1 (0.56) CTNNB1WNT3AALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11673885-B2 γ-diketones as Wnt/β-catenin signaling pathway activators BIOSPLICE THERAPEUTICS, INC. (US) 2023-06-13 US disclosed
US-20230053726-A1 GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS VICKERS-SPLICE CO-INVESTMENT LLC (KY) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230053726-A1 GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS GSK3A, GSK3B, WNT1 PLK1 397/4885CTNNB1 6/4885WNT3A 4/4885
US-11673885-B2 γ-diketones as Wnt/β-catenin signaling pathway activators GSK3A, GSK3B, WNT1 PLK1 376/4885CTNNB1 5/4885WNT3A 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.